Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

271 ARTÍCULOS , VIENDO DEL 166 AL 180

[Blood Biomarkers for Alzheimer's Disease: Current Status and Prospects]

Ikeuchi T.

Brain Nerve. 2024 Sep;76(9):1045-1052. doi: 10.11477/mf.1416202730.

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease

Hu Y, Cho M, Sachdev P, Dage J, Hendrix S, Hansson O, Bateman RJ, Hampel H.

Med. 2024 Oct 11;5(10):1206-1226. doi: 10.1016/j.medj.2024.08.004. Epub 2024 Sep 9.

Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review

Mitolo M, Lombardi G, Manca R, Nacmias B, Venneri A.

J Neurol. 2024 Nov;271(11):7120-7140. doi: 10.1007/s00415-024-12674-w. Epub 2024 Sep 12.

[Chinese guideline for clinical application of fluid biomarkers for Alzheimer's disease(2024 edition)]

National Health Commission Capacity Building and Continuing Education Center; Chinese Neuroscience Society; Aging Biomarker Consortium; Writing Group for the Chinese Guideline for Clinical Application of Fluid Biomarkers for Alzheimer′s Disease.

Zhonghua Yi Xue Za Zhi. 2024 Sep 10;104(35):3292-3306. doi: 10.3760/cma.j.cn112137-20240523-01174.

Moving Towards Ethical-Practical Recommendations for Alzheimer's Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects

Schicktanz S, Alpinar-Segawa Z, Ulitsa N, Perry J, Werner P.

J Alzheimers Dis. 2024;101(4):1063-1081. doi: 10.3233/JAD-231137.

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease

Collij LE, Mastenbroek SE, Mattsson-Carlgren N, Strandberg O, Smith R, Janelidze S, Palmqvist S, Ossenkoppele R, Hansson O.

Nat Commun. 2024 Sep 14;15(1):8061. doi: 10.1038/s41467-024-52299-1.

Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia

Méndez-Barrio C, Medina-Rodríguez M, Mendoza-Vázquez G, García-Roldán E, Rodrigo-Herrero S, Luque-Tirado A, Almodóvar-Sierra Á, Franco-Macías E.

J Alzheimers Dis. 2024;101(3):877-887. doi: 10.3233/JAD-240689.

Network Medicine Approach Unravels Endophenotype Signature in Alzheimer's Disease through Large-Scale Comparative Proteomics Analysis: Vascular Dysfunction as a Prime Example

Dai Z, Pang X, Chen N, Fan X, Liu W, Liu J, Chen Z, Fang S, Cai C, Fang J.

J Chem Inf Model. 2024 Oct 14;64(19):7758-7771. doi: 10.1021/acs.jcim.4c01344. Epub 2024 Sep 25.

Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration According to Sociodemographic Characteristics and Chronic Health Conditions

Zheng HT, Wu Z, Mielke MM, Murray AM, Ryan J.

J Prev Alzheimers Dis. 2024;11(5):1189-1197. doi: 10.14283/jpad.2024.142.

A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer's Disease

Chen T, Hutchison RM, Rubel C, Murphy J, Xie J, Montenigro P, Cheng W, Fraser K, Dent G, Hendrix S, Hansson O, Aisen P, Tian Y, O'Gorman J.

J Prev Alzheimers Dis. 2024;11(5):1228-1240. doi: 10.14283/jpad.2024.126.

Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease

Toda Y, Iwatsubo T, Nakamura Y, Matsuda N, Miyata M, Jin M, Chen T, Kuribayashi K, Tian Y, Hughes R, Yamamoto J, Muralidharan KK, Rubel C, Hutchison RM, Budd Haeberlein S.

J Prev Alzheimers Dis. 2024;11(5):1260-1269. doi: 10.14283/jpad.2024.106.

Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease

Mielke MM, Anderson M, Ashford JW, Jeromin A, Lin PJ, Rosen A, Tyrone J, Vandevrede L, Willis DR, Hansson O, Khachaturian AS, Schindler SE, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Braunstein JB, Burnham SC, de Oliveira FF, Hu YH, Mattke S, Merali Z, Monane M, Sabbagh MN, Shobin E, Weiner M, Udeh-Momoh CT.

Alzheimers Dement. 2024 Nov;20(11):8216-8224. doi: 10.1002/alz.14184. Epub 2024 Oct 1.

Alzheimer's disease biomarkers and the tyranny of treatment

Karlawish J, Grill JD.

EBioMedicine. 2024 Oct;108:105291. doi: 10.1016/j.ebiom.2024.105291. Epub 2024 Oct 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias